Home/Filings/4/A/0001209191-21-023381
4/A//SEC Filing

Grigoriadis Dimitri E. 4/A

Accession 0001209191-21-023381

CIK 0000914475other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 6:21 AM ET

Size

5.6 KB

Accession

0001209191-21-023381

Insider Transaction Report

Form 4/AAmended
Period: 2021-02-05
Grigoriadis Dimitri E.
Vice President, Research
Transactions
  • Award

    Stock Option

    2021-02-08+42,04242,042 total
    Exercise: $117.63Exp: 2031-02-08Common Stock (42,042 underlying)
Footnotes (1)
  • [F1]Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 8, 2021 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.

Issuer

NEUROCRINE BIOSCIENCES INC

CIK 0000914475

Entity typeother

Related Parties

1
  • filerCIK 0001423838

Filing Metadata

Form type
4/A
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 6:21 AM ET
Size
5.6 KB